SUMMIT (dpa-AFX) - Shares of Achaogen Inc. (AKAO) rose nearly 13% on
Thursday, following a $20 million contract option awarded by BARDA to support
the development of the company's lead product candidate Plazomicin.
Plazomicin is under a...
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.